Hyperkalemia with Combined Aldosterone and Angiotensin Blockade in Patients with Heart Failure

    loading  Checking for direct PDF access through Ovid


This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the US, and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on prevention and treatment — if they keep current with developments in drug therapy.

Related Topics

    loading  Loading Related Articles